GlassScriptPhysician profile
Van Chi Vong
NPI 1427112358
$1,476.69
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $54.83 · 2021: $98.22 · 2022: $319 · 2023: $406 · 2024: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $285.57 | 2019-2023 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $228.46 | 2022-2024 | |
| Abbvie INC. | $190.52 | 2019-2022 | |
| Novo Nordisk INC | $118.71 | 2021-2023 | Rybelsus, Ozempic |
| Hikma Pharmaceuticals USA | $88.91 | 2021-2022 | |
| Astellas Pharma US INC | $70.88 | 2019 | |
| Novartis Pharmaceuticals Corporation | $60.01 | 2023 | |
| Radius Health, INC. | $58.74 | 2019-2024 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.87 | 2019-2022 | |
| Glaxosmithkline, LLC. | $46.68 | 2021-2023 | Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $35.68 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $33.41 | 2024 | |
| Amarin Pharma, INC. | $32.29 | 2019 | |
| Corium, LLC | $24.79 | 2022 | |
| Dexcom, INC. | $24.35 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $23.09 | 2021 | |
| Xeris Pharmaceuticals, INC. | $22.76 | 2023 | Gvoke Hypopen |
| Pfizer INC. | $20.45 | 2023 | |
| Lilly USA, LLC | $19.01 | 2019 | |
| Scilex Pharmaceuticals INC. | $18.66 | 2023 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Van Vong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.